Whats Inside: Evidence-Based, Action-Focused This guide bridges the gap between knowing what to doand actually doing it
You only have to look to the recent reports of individual impacted by large-scale compounding to realise the dangers posed. Recent Developments In December 2024, Vivani Medical Inc., a pioneering biopharmaceutical company, declared the initiation of its first-in-human clinical trial, LIBERATE-1 at two centers in Australia for investigating the safety, tolerability and complete pharmacokinetic profile of a miniature, GLP-1 (exenatide) implant through the NPM-115 clinical program
Strategy : 1-2 g/day in a 12-week course, to be repeated 2-3 times per year
Severe, persistent dry mouth combined with other symptoms like difficulty swallowing, mouth sores, or signs of oral infection warrants prompt evaluation
Doctors often start people on a low dose and gradually increase it to minimize these effects
Our goal is to guide you toward a healthier lifestyle that brings lasting vitality, self-assurance , and a renewed sense of balance
